The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1

The ESX-1 secretion system is a major determinant of Mycobacterium tuberculosis virulence, although the pathogenic mechanisms resulting from ESX-1-mediated transport remain unclear. By global transcriptional profiling of tissues from mice infected with either wild-type or ESX-1 mutant bacilli, we found that host genes controlled by ESX-1 in vivo are predominantly IFN regulated. ESX-1-mediated secretion is required for the production of host type I IFNs during infection in vivo and in macrophages in vitro. The macrophage signaling pathway leading to the production of type I IFN required the host kinase TANK-binding kinase 1 and occurs independently of TLR signaling. Importantly, the induction of type I IFNs during M. tuberculosis infection is a pathogenic mechanism as mice lacking the type I IFNR were more restrictive for bacterial growth in the spleen than wild-type mice, although growth in the lung was unaffected. We propose that the ESX-1 secretion system secretes effectors into the cytosol of infected macrophages, thereby triggering the type I IFN response for the manipulation of host immunity.

[1]  S. Grinstein,et al.  The ESAT‐6/CFP‐10 secretion system of Mycobacterium marinum modulates phagosome maturation , 2006, Cellular microbiology.

[2]  Mark Johnson,et al.  Secreted Proteins from Mycobacterium tuberculosis Gain Access to the Cytosolic MHC Class-I Antigen-Processing Pathway1 , 2006, The Journal of Immunology.

[3]  H. Kornfeld,et al.  Macrophage Apoptosis in Response to High Intracellular Burden of Mycobacterium tuberculosis Is Mediated by a Novel Caspase-Independent Pathway1 , 2006, The Journal of Immunology.

[4]  Juan F Medrano,et al.  Comparison of gene coverage of mouse oligonucleotide microarray platforms , 2006, BMC Genomics.

[5]  M. Netea,et al.  NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis , 2005, PLoS pathogens.

[6]  Christopher M Hickey,et al.  Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-αβ Receptor and STAT11 , 2005, The Journal of Immunology.

[7]  M. Chase,et al.  Mutually dependent secretion of proteins required for mycobacterial virulence. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Jim Norman,et al.  Structure and function of the complex formed by the tuberculosis virulence factors CFP‐10 and ESAT‐6 , 2005, The EMBO journal.

[9]  G. Cheng,et al.  The host type I interferon response to viral and bacterial infections , 2005, Cell Research.

[10]  Ryan M. O’Connell,et al.  Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 11 , 2005, The Journal of Immunology.

[11]  Ryan M. O’Connell,et al.  Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. , 2005, Journal of Immunology.

[12]  D. Sherman,et al.  Tuberculous Granuloma Formation Is Enhanced by a Mycobacterium Virulence Determinant , 2004, PLoS biology.

[13]  B. Finlay,et al.  Evasive Maneuvers by Secreted Bacterial Proteins to Avoid Innate Immune Responses , 2004, Current Biology.

[14]  D. Portnoy,et al.  Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes , 2004, The Journal of experimental medicine.

[15]  Ryan M. O’Connell,et al.  Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection , 2004, The Journal of experimental medicine.

[16]  E. Unanue,et al.  Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection , 2004, The Journal of experimental medicine.

[17]  G. Cheng,et al.  Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection , 2004, The Journal of experimental medicine.

[18]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.

[19]  D. Sherman,et al.  Individual RD1‐region genes are required for export of ESAT‐6/CFP‐10 and for virulence of Mycobacterium tuberculosis , 2004, Molecular microbiology.

[20]  T. Mueller,et al.  Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation1 , 2003, The Journal of Immunology.

[21]  S. Raghavan,et al.  Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Eisenberg,et al.  The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Guo-Ping Zhou,et al.  Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.

[24]  T. Maniatis,et al.  IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.

[25]  Michael Weiden,et al.  Inhibition of Response to Alpha Interferon by Mycobacterium tuberculosis , 2003, Infection and Immunity.

[26]  S. Akira,et al.  The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1 , 2003, The Journal of Immunology.

[27]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[28]  D. Portnoy,et al.  Innate recognition of bacteria by a macrophage cytosolic surveillance pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Modlin,et al.  Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. , 2002, Current opinion in immunology.

[30]  S. Taki Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. , 2002, Cytokine & growth factor reviews.

[31]  N. Boéchat,et al.  Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG , 2002, Infection and Immunity.

[32]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[33]  E. Lander,et al.  Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Gordon,et al.  Conclusive Evidence That the Major T-cell Antigens of the Mycobacterium tuberculosis Complex ESAT-6 and CFP-10 Form a Tight, 1:1 Complex and Characterization of the Structural Properties of ESAT-6, CFP-10, and the ESAT-6 CFP-10 Complex IMPLICATIONS FOR PATHOGENESIS AND VIRULENCE* , 2002 .

[35]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[36]  O. Schneewind,et al.  Protein secretion and the pathogenesis of bacterial infections. , 2001, Genes & development.

[37]  Ilkka Julkunen,et al.  Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.

[38]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Modlin,et al.  Activation of toll-like receptors by microbial lipoproteins. , 2001, Scandinavian journal of infectious diseases.

[40]  S. Ehlers,et al.  Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung , 2000, Infection and Immunity.

[41]  W. Rom,et al.  Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein β Expression1 , 2000, The Journal of Immunology.

[42]  D. Baltimore,et al.  NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.

[43]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[44]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[45]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[47]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[48]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.